MeSH tree: C10.574.950
The core facilities of the Cibio Department of the University of Trento have all taken part in a study on amyotrophic lateral sclerosis (ALS) to better understand the molecular mechanisms of slow-progressing cases. The study ...
May 5, 2026
0
11
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease that causes the progressive loss of motor neurons, which in most cases leads to respiratory failure within three to five years after diagnosis. In this context, ...
Apr 30, 2026
0
8
Researchers at WashU Medicine have uncovered new molecular insights into Alzheimer's disease, Parkinson's disease and other forms of dementia by analyzing thousands of proteins in both cerebrospinal fluid and blood plasma. ...
Apr 24, 2026
0
20
Researchers at LMU have developed a human cell model that replicates key mechanisms of neurodegenerative diseases—with potential for novel therapies. The paper is published in the journal Science Translational Medicine.
Apr 23, 2026
0
8
New research from Washington University School of Medicine in St. Louis adds to growing evidence that helping brain cells break down and eliminate their own cellular waste is a promising treatment strategy for a variety of ...
Mar 31, 2026
0
13
The symptom profiles of different neurodegenerative diseases often overlap, and diagnosing age-related cognitive symptoms is complex. A patient may have multiple overlapping disease processes in the brain at the same time, ...
Mar 31, 2026
0
16
A landmark research paper for the first time maps the genetics of how individual regions of the brain age—and why some of those regions are the very ones most ravaged by Alzheimer's and dementia. Published in the journal ...
Mar 26, 2026
0
24
People with Alzheimer's disease often have other neurodegenerative conditions as well, including a less-understood disorder called frontotemporal lobar degeneration (FTLD). While a precise diagnosis of FTLD has only been ...
Mar 16, 2026
0
4
Loss of communication can be among the most devastating symptoms for patients with paralysis. A new study by investigators from Mass General Brigham Neuroscience Institute and Brown University describes an investigational ...
Mar 16, 2026
0
13
In a phase 2b clinical trial, an investigational oral therapy called PrimeC was found to be safe and well tolerated in people living with amyotrophic lateral sclerosis (ALS), with exploratory findings suggesting target engagement ...
Mar 16, 2026
0
9
